Evidence map›Paper›PMID 37808248›Full record

ArticleMolecular and clinical oncology2023

Extra‑abdominal recurrent aggressive fibromatosis: A case series and a literature review.

Saywan K Asaad, Ari M Abdullah, Shkar Ali Abdalrahman, Fattah H Fattah, Soran H Tahir, Choman Sabah Omer, Rezheen J Rashid, Marwan N Hassan, Shvan H Mohammed, Fahmi H Kakamad and 1 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Molecular and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Saywan K AsaadDepartment of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
Ari M AbdullahDepartment of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
Shkar Ali AbdalrahmanDepartment of Surgery, Shar Hospital, Sulaimani, Kurdistan 46001, Iraq.
Fattah H FattahDepartment of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
Soran H TahirDepartment of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
Choman Sabah OmerDepartment of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
Rezheen J RashidDepartment of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
Marwan N HassanDepartment of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
Shvan H MohammedKscien Organization, Hamdi Str, Azadi Mall, Sulaimani, Kurdistan 46001, Iraq.
Fahmi H KakamadDepartment of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
Berun A AbdallaDepartment of Scientific Affairs, Smart Health Tower, Sulaimani, Kurdistan 46001, Iraq.
University of Sulaimani · IQKurdistan Regional Government · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aggressive fibromatosis is a rare clonal proliferative tumor arising from mesenchymal cells in the fascia and musculoaponeurotic structures. The aim of the present study was to describe several cases of extra-abdominal recurrent aggressive fibromatosis. The present study was a single-center retrospective case series of patients with recurrent aggressive fibromatosis. The cases were managed at a single private facility. A total of 9 patients with recurrent fibromatosis were included. The mean and median ages of the patients were 29 and 30 years, respectively. In total, two thirds (66.67%) of the cases were female. A negative previous medical history was reported in 7 cases (77.7%), and diabetes and hypertension were reported in 1 case (11.1%). Overall, only 1 case (11.1%) had a family history of breast fibromatosis. The time interval between primary tumor resection and recurrent presentation was 28 months. In 6 cases (66.7%), the tumor was located in the extremities. Pain was the most common presenting symptom in 6 cases (66.7%). All patients had their recurring tumor surgically removed, followed by radiation in 5 cases. The resection margin was positive in 4 cases (44.4%). Each patient was subjected to a careful three-month follow-up for recurrences. On the whole, the present study demonstrates that despite the fact that several therapeutic approaches for extra-abdominal recurrent aggressive fibromatosis have been described in the literature, there is a significant likelihood of recurrence following resection.

Indexed as

desmoid-like fibromatosisextra-abdominal aggressive fibromatosisradiotherapyrecurrent tumorresection margin

Identifiers

PMID37808248
PMCPMC10557105
OpenAlexW4386513728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.